vs
FMC CORP(FMC)与Roper Technologies(ROP)财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是FMC CORP的1.9倍($2.1B vs $1.1B),Roper Technologies净利率更高(15.8% vs -158.8%,领先174.6%),Roper Technologies同比增速更快(11.3% vs -11.5%),FMC CORP自由现金流更多($631.1M vs $507.0M),过去两年Roper Technologies的营收复合增速更高(10.5% vs 8.6%)
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业,1883年创立之初以生产杀虫剂为主,后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车,目前在全球拥有7000名员工,业务布局广泛。
罗珀技术公司是一家专注于科技领域的控股企业,通过持有并运营多家不同细分赛道的科技公司,在科技产业投资与资产管理领域形成了成熟的业务体系,在全球相关市场具备较高的行业影响力。
FMC vs ROP — 直观对比
营收规模更大
ROP
是对方的1.9倍
$1.1B
营收增速更快
ROP
高出22.8%
-11.5%
净利率更高
ROP
高出174.6%
-158.8%
自由现金流更多
FMC
多$124.1M
$507.0M
两年增速更快
ROP
近两年复合增速
8.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.1B | $2.1B |
| 净利润 | $-1.7B | $331.0M |
| 毛利率 | 39.8% | 69.4% |
| 营业利润率 | -130.8% | 27.2% |
| 净利率 | -158.8% | 15.8% |
| 营收同比 | -11.5% | 11.3% |
| 净利润同比 | -10457.1% | 842.6% |
| 每股收益(稀释后) | $-13.77 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FMC
ROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $542.2M | $2.0B | ||
| Q2 25 | $1.1B | $1.9B | ||
| Q1 25 | $791.4M | $1.9B | ||
| Q4 24 | $1.2B | $1.9B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.0B | $1.7B |
净利润
FMC
ROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $-1.7B | $428.4M | ||
| Q3 25 | $-569.3M | $398.5M | ||
| Q2 25 | $66.7M | $378.3M | ||
| Q1 25 | $-15.5M | $331.1M | ||
| Q4 24 | $-16.3M | $462.3M | ||
| Q3 24 | $65.0M | $367.9M | ||
| Q2 24 | $295.1M | $337.1M |
毛利率
FMC
ROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 39.8% | 69.5% | ||
| Q3 25 | 23.8% | 69.5% | ||
| Q2 25 | 38.7% | 69.2% | ||
| Q1 25 | 40.0% | 68.7% | ||
| Q4 24 | 42.9% | 68.3% | ||
| Q3 24 | 36.3% | 69.2% | ||
| Q2 24 | 38.3% | 69.5% |
营业利润率
FMC
ROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | -130.8% | 28.6% | ||
| Q3 25 | -73.1% | 28.4% | ||
| Q2 25 | 12.0% | 28.2% | ||
| Q1 25 | 7.4% | 27.9% | ||
| Q4 24 | 19.2% | 28.0% | ||
| Q3 24 | 12.7% | 28.1% | ||
| Q2 24 | 6.0% | 28.8% |
净利率
FMC
ROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | -158.8% | 20.8% | ||
| Q3 25 | -105.0% | 19.8% | ||
| Q2 25 | 6.3% | 19.5% | ||
| Q1 25 | -2.0% | 17.6% | ||
| Q4 24 | -1.3% | 24.6% | ||
| Q3 24 | 6.1% | 20.8% | ||
| Q2 24 | 28.4% | 19.6% |
每股收益(稀释后)
FMC
ROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $-13.77 | $3.97 | ||
| Q3 25 | $-4.52 | $3.68 | ||
| Q2 25 | $0.53 | $3.49 | ||
| Q1 25 | $-0.12 | $3.06 | ||
| Q4 24 | $-0.13 | $4.29 | ||
| Q3 24 | $0.52 | $3.40 | ||
| Q2 24 | $2.35 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $584.5M | $382.9M |
| 总债务越低越好 | $3.4B | $9.7B |
| 股东权益账面价值 | $2.1B | $18.8B |
| 总资产 | $9.7B | $34.6B |
| 负债/权益比越低杠杆越低 | 1.62× | 0.52× |
8季度趋势,按日历期对齐
现金及短期投资
FMC
ROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $584.5M | $297.4M | ||
| Q3 25 | $497.7M | $320.0M | ||
| Q2 25 | $438.2M | $242.4M | ||
| Q1 25 | $315.3M | $372.8M | ||
| Q4 24 | $357.3M | $188.2M | ||
| Q3 24 | $416.7M | $269.6M | ||
| Q2 24 | $471.5M | $251.5M |
总债务
FMC
ROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | $3.4B | $9.3B | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.1B | $7.6B | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.1B | — |
股东权益
FMC
ROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $2.1B | $19.9B | ||
| Q3 25 | $3.8B | $20.0B | ||
| Q2 25 | $4.4B | $19.6B | ||
| Q1 25 | $4.4B | $19.2B | ||
| Q4 24 | $4.5B | $18.9B | ||
| Q3 24 | $4.6B | $18.5B | ||
| Q2 24 | $4.6B | $18.1B |
总资产
FMC
ROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $9.7B | $34.6B | ||
| Q3 25 | $12.1B | $34.6B | ||
| Q2 25 | $12.3B | $33.2B | ||
| Q1 25 | $11.8B | $31.4B | ||
| Q4 24 | $11.7B | $31.3B | ||
| Q3 24 | $12.2B | $31.6B | ||
| Q2 24 | $12.1B | $29.8B |
负债/权益比
FMC
ROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | 1.62× | 0.47× | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | 0.69× | 0.40× | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $657.1M | — |
| 自由现金流经营现金流 - 资本支出 | $631.1M | $507.0M |
| 自由现金流率自由现金流/营收 | 58.3% | 24.2% |
| 资本支出强度资本支出/营收 | 2.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-102.5M | — |
8季度趋势,按日历期对齐
经营现金流
FMC
ROP
| Q1 26 | — | — | ||
| Q4 25 | $657.1M | $738.0M | ||
| Q3 25 | $-184.2M | $869.5M | ||
| Q2 25 | $65.9M | $404.1M | ||
| Q1 25 | $-545.0M | $528.7M | ||
| Q4 24 | $427.9M | $722.2M | ||
| Q3 24 | $159.5M | $755.4M | ||
| Q2 24 | $292.2M | $384.1M |
自由现金流
FMC
ROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $631.1M | — | ||
| Q3 25 | $-207.9M | — | ||
| Q2 25 | $50.9M | — | ||
| Q1 25 | $-576.6M | — | ||
| Q4 24 | $406.3M | — | ||
| Q3 24 | $143.8M | — | ||
| Q2 24 | $282.3M | — |
自由现金流率
FMC
ROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 58.3% | — | ||
| Q3 25 | -38.3% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | -72.9% | — | ||
| Q4 24 | 33.2% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 27.2% | — |
资本支出强度
FMC
ROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.0% | — |
现金转化率
FMC
ROP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | 0.99× | 1.07× | ||
| Q1 25 | — | 1.60× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | 2.45× | 2.05× | ||
| Q2 24 | 0.99× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMC
| Insecticides | $440.3M | 41% |
| Herbicides | $378.8M | 35% |
| Fungicides | $140.4M | 13% |
| Plant Health | $65.6M | 6% |
| Other | $45.0M | 4% |
ROP
暂无分部数据